Risk of preterm delivery in non-diabetic women with polycystic ovarian syndrome

Journal of Perinatology

Volumn 32, Issue 10, 2012, Pages 770-776

  Yamamoto, M ^a   Feigenbaum, S L ^a,b   Crites, Y ^a,b   Escobar, G J ^a,b,c   Yang, J ^c   Ferrara, A ^c   Lo, J C ^b,c  

^a KAISER PERMANENTE   (United States)

^b KAISER PERMANENTE MEDICAL CENTER   (United States)

^c DIVISION OF RESEARCH   (United States)

Author keywords

polycystic ovary syndrome; pregnancy; preterm delivery

Indexed keywords

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; FETUS DEATH; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MATERNAL AGE; MORBIDITY; NULLIPARA; OVARY POLYCYSTIC DISEASE; PREMATURE FETUS MEMBRANE RUPTURE; PREMATURE LABOR; RACE; RETROSPECTIVE STUDY; RISK ASSESSMENT; UTERINE CERVIX INCOMPETENCE;

ADULT; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY OUTCOME; PREMATURE BIRTH; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84867072918     PISSN: 07438346     EISSN: 14765543     Source Type: Journal    
DOI: 10.1038/jp.2011.194     Document Type: Article

References (60)

1. Diamanti-Kandarakis E, Kouli CR, Bergiele AT, Filandra FA, Tsianateli TC, Spina GG et al. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999; 84(11): 4006-4011.
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study. J Clin Endocrinol Metab 1998; 83(9): 3078-3082.
3. Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000; 85(7): 2434-2438.
4. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004; 89(6): 2745-2749.
5. Repaci A, Gambineri A, Pasquali R. The role of low-grade inflammation in the polycystic ovary syndrome. Mol Cell Endocrinol 2010; 335(1): 30-41.
6. Glintborg D, Andersen M. An update on the pathogenesis, inflammation, and metabolism in hirsutism and polycystic ovary syndrome. Gynecol Endocrinol 2010; 26(4): 281-296.
7. Sagle M, Bishop K, Ridley N, Alexander FM, Michel M, Bonney RC et al. Recurrent early miscarriage and polycystic ovaries. BMJ 1988; 297(6655): 1027-1028.
8. Palomba S, Falbo A, Russo T, Tolino A, Orio F, Zullo F. Pregnancy in women with polycystic ovary syndrome: the effect of different phenotypes and features on obstetric and neonatal outcomes. Fertil Steril 2010; 94(5): 1805-1811.
9. Lo JC, Feigenbaum SL, Escobar GJ, Yang J, Crites YM, Ferrara A. Increased prevalence of gestational diabetes mellitus among women with diagnosed polycystic ovary syndrome: a population-based study. Diabetes Care 2006; 29(8): 1915-1917.
10. Mikola M, Hiilesmaa V, Halttunen M, Suhonen L, Tiitinen A. Obstetric outcome in women with polycystic ovarian syndrome. Hum Reprod 2001; 16(2): 226-229.
11. Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol 1999; 94(2): 194-197.
12. Boomsma CM, Fauser BC, Macklon NS. Pregnancy complications in women with polycystic ovary syndrome. Semin Reprod Med 2008; 26(1): 72-84.
13. Alshammari A, Hanley A, Ni A, Tomlinson G, Feig DS. Does the presence of polycystic ovary syndrome increase the risk of obstetrical complications in women with gestational diabetes? J Matern Fetal Neonatal Med 2010; 23(6): 545-549.
14. Iavazzo C, Vitoratos N. Polycystic ovarian syndrome and pregnancy outcome. Arch Gynecol Obstet 2010; 282(3): 235-239.
15. Altieri P, Gambineri A, Prontera O, Cionci G, Franchina M, Pasquali R. Maternal polycystic ovary syndrome may be associated with adverse pregnancy outcomes. Eur J Obstet Gynecol Reprod Biol 2010; 149(1): 31-36.
16. Kashyap S, Claman P. Polycystic ovary disease and the risk of pregnancy-induced hypertension. J Reprod Med 2000; 45(12): 991-994.
17. Weerakiet S, Srisombut C, Rojanasakul A, Panburana P, Thakkinstian A, Herabutya Y. Prevalence of gestational diabetes mellitus and pregnancy outcomes in Asian women with polycystic ovary syndrome. Gynecol Endocrinol 2004; 19(3): 134-140.
18. Urman B, Sarac E, Dogan L, Gurgan T. Pregnancy in infertile PCOD patients. Complications and outcome. J Reprod Med 1997; 42(8): 501-505.
19. Boomsma CM, Eijkemans MJ, Hughes EG, Visser GH, Fauser BC, Macklon NS. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update 2006; 12(6): 673-683.
20. Nawaz FH, Khalid R, Naru T, Rizvi J. Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome? J Obstet Gynaecol Res 2008; 34(5): 832-837.
21. Sir-Petermann T, Hitchsfeld C, Maliqueo M, Codner E, Echiburu B, Gazitua R et al. Birth weight in offspring of mothers with polycystic ovarian syndrome. Hum Reprod 2005; 20(8): 2122-2126.
22. Wen SW, Goldenberg RL, Cutter GR, Hoffman HJ, Cliver SP. Intrauterine growth retardation and preterm delivery: prenatal risk factors in an indigent population. Am J Obstet Gynecol 1990; 162(1): 213-218.
23. Martin JA, Kochanek KD, Strobino DM, Guyer B, MacDorman MF. Annual summary of vital statisticsF2003. Pediatrics 2005; 115(3): 619-634.
24. Lumley J. The epidemiology of preterm birth. Baillieres Clin Obstet Gynaecol 1993; 7(3): 477-498.
25. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008; 371(9606): 75-84.
26. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004; 81(1): 19-25.
27. Cunningham FG, Leveno KJ, Blood SL, Hauth JC, Gilstrap LC, Wenstrom KD. Williams Obstetrics, 22nd edn. McGraw-Hill Medical Publishing Division: New York, 2005.
28. ACOG Practice Bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol 2001; 98(suppl 1): 177-185.
29. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. Obstet Gynecol 2002; 99(1): 159-167.
30. ACOG practice bulletin. Management of preterm labor. Number 43, May 2003. Int J Gynaecol Obstet 2003; 82(1): 127-135.
31. ACOG Practice Bulletin. No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007; 109(4): 1007-1019.
32. ACOG Practice Bulletin. Cervical insufficiency. Obstet Gynecol (2003 Reaffirmed 2008); 102(5 Pt 1): 1091-1099.
33. Lewit EM, Baker LS, Corman H, Shiono PH. The direct cost of low birth weight. Future Child 1995; 5(1): 35-56.
34. Davidoff MJ, Dias T, Damus K, Russell R, Bettegowda VR, Dolan S et al. Changes in the gestational age distribution among U.S. singleton births: impact on rates of late preterm birth, 1992 to 2002. Semin Perinatol 2006; 30(1): 8-15.
35. Hamilton BE, Minino AM, Martin JA, Kochanek KD, Strobino DM, Guyer B. Annual summary of vital statistics: 2005. Pediatrics 2007; 119(2): 345-360.
36. Martin JA, Hamilton BE, Sutton PD, Ventura SJ, Menacker F, Kirmeyer S et al. Births: final data for 2005. Natl Vital Stat Rep 2007; 56(6): 1-103.
37. Muglia LJ, Katz M. The enigma of spontaneous preterm birth. N Engl J Med 2010; 362(6): 529-535.
38. Rao AK, Daniels K, El-Sayed YY, Moshesh MK, Caughey AB. Perinatal outcomes among Asian American and Pacific Islander women. Am J Obstet Gynecol 2006; 195(3): 834-838.
39. Alexander GR, Wingate MS, Mor J, Boulet S. Birth outcomes of Asian-Indian-Americans. Int J Gynaecol Obstet 2007; 97(3): 215-220.
40. Wong LF, Caughey AB, Nakagawa S, Kaimal AJ, Tran SH, Cheng YW. Perinatal outcomes among different Asian-American subgroups. Am J Obstet Gynecol 2008; 199(4): 382, e381-386.
41. Diamanti-Kandarakis E, Alexandraki K, Piperi C, Protogerou A, Katsikis I, Paterakis T et al. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest 2006; 36(10): 691-697.
42. Chen MJ, Chen HF, Chen SU, Ho HN, Yang YS, Yang WS. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome. Fertil Steril 2009; 92(6): 2041-2044.
43. Gomez-Lopez N, Laresgoiti-Servitje E, Olson DM, Estrada-Gutierrez G, Vadillo-Ortega F. The role of chemokines in term and premature rupture of the fetal membranes: a review. Biol Reprod 2010; 82(5): 809-814.
44. Arntzen KJ, Kjollesdal AM, Halgunset J, Vatten L, Austgulen R. TNF, IL-1, IL-6, IL-8 and soluble TNF receptors in relation to chorioamnionitis and premature labor. J Perinat Med 1998; 26(1): 17-26.
45. Romero R, Ceska M, Avila C, Mazor M, Behnke E, Lindley I. Neutrophil attractant/activating peptide-1/interleukin-8 in term and preterm parturition. Am J Obstet Gynecol 1991; 165(4 Pt 1): 813-820.
46. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS et al. An elevated amniotic fluid matrix metalloproteinase-8 level at the time of mid-trimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am J Obstet Gynecol 2001; 185(5): 1162-1167.
47. Ghidini A, Jenkins CB, Spong CY, Pezzullo JC, Salafia CM, Eglinton GS. Elevated amniotic fluid interleukin-6 levels during the early second trimester are associated with greater risk of subsequent preterm delivery. Am J Reprod Immunol 1997; 37(3): 227-231.
48. Wenstrom KD, Andrews WW, Hauth JC, Goldenberg RL, DuBard MB, Cliver SP. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am J Obstet Gynecol 1998; 178(3): 546-550.
49. Iavazzo C, Tassis K, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D et al. The role of human beta defensins 2 and 3 in the second trimester amniotic fluid in predicting preterm labor and premature rupture of membranes. Arch Gynecol Obstet 2010; 281(5): 793-799.
50. Puchner K, Iavazzo C, Gourgiotis D, Boutsikou M, Baka S, Hassiakos D et al. Midtrimester amniotic fluid interleukins (IL-1beta, IL-10 and IL-18) as possible predictors of preterm delivery. In Vivo 2011; 25(1): 141-148.
51. Filicori M, Cognigni GE, Gamberini E, Troilo E, Parmegiani L, Bernardi S. Impact of medically assisted fertility on preterm birth. BJOG 2005; 112(Suppl 1): 113-117.
52. Wang JX, Norman RJ, Kristiansson P. The effect of various infertility treatments on the risk of preterm birth. Hum Reprod 2002; 17(4): 945-949.
53. Wisborg K, Ingerslev HJ, Henriksen TB. In vitro fertilization and preterm delivery, low birth weight, and admission to the neonatal intensive care unit: a prospective follow-up study. Fertil Steril 2010; 94(6): 2102-2106.
54. McDonald SD, Han Z, Mulla S, Murphy KE, Beyene J, Ohlsson A. Preterm birth and low birth weight among in vitro fertilization singletons: a systematic review and meta-analyses. Eur J Obstet Gynecol Reprod Biol 2009; 146(2): 138-148.
55. Allen C, Bowdin S, Harrison RF, Sutcliffe AG, Brueton L, Kirby G et al. Pregnancy and perinatal outcomes after assisted reproduction: a comparative study. Ir J Med Sci 2008; 177(3): 233-241.
56. Helmerhorst FM, Perquin DA, Donker D, Keirse MJ. Perinatal outcome of singletons and twins after assisted conception: a systematic review of controlled studies. BMJ 2004; 328(7434): 261.
57. Jackson RA, Gibson KA, Wu YW, Croughan MS. Perinatal outcomes in singletons following in vitro fertilization: a meta-analysis. Obstet Gynecol 2004; 103(3): 551-563.
58. Halliday J. Outcomes of IVF conceptions: are they different? Best Pract Res Clin Obstet Gynaecol 2007; 21(1): 67-81.
59. Badawy A, Shokeir T, Allam AF, Abdelhady H. Pregnancy outcome after ovulation induction with aromatase inhibitors or clomiphene citrate in unexplained infertility. Acta Obstet Gynecol Scand 2009; 88(2): 187-191.
60. Jaques AM, Amor DJ, Baker HW, Healy DL, Ukoumunne OC, Breheny S et al. Adverse obstetric and perinatal outcomes in subfertile women conceiving without assisted reproductive technologies. Fertil Steril 2010; 94(7): 2674-2679.